HUE047044T2 - Piperazin-származékok és gyógyszerként történõ alkalmazásuk - Google Patents
Piperazin-származékok és gyógyszerként történõ alkalmazásukInfo
- Publication number
- HUE047044T2 HUE047044T2 HUE14784235A HUE14784235A HUE047044T2 HU E047044 T2 HUE047044 T2 HU E047044T2 HU E14784235 A HUE14784235 A HU E14784235A HU E14784235 A HUE14784235 A HU E14784235A HU E047044 T2 HUE047044 T2 HU E047044T2
- Authority
- HU
- Hungary
- Prior art keywords
- medicament
- piperazine derivatives
- piperazine
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13188904 | 2013-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE047044T2 true HUE047044T2 (hu) | 2020-04-28 |
Family
ID=49354583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE14784235A HUE047044T2 (hu) | 2013-10-16 | 2014-10-15 | Piperazin-származékok és gyógyszerként történõ alkalmazásuk |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9233953B2 (hu) |
| EP (1) | EP3057963B1 (hu) |
| JP (1) | JP6483105B2 (hu) |
| KR (1) | KR102281284B1 (hu) |
| CN (1) | CN105636961B (hu) |
| AR (1) | AR098037A1 (hu) |
| AU (1) | AU2014336258B2 (hu) |
| BR (1) | BR112016008062B1 (hu) |
| CA (1) | CA2926754C (hu) |
| CL (1) | CL2016000884A1 (hu) |
| DK (1) | DK3057963T3 (hu) |
| EA (1) | EA029313B1 (hu) |
| ES (1) | ES2745555T3 (hu) |
| HU (1) | HUE047044T2 (hu) |
| IL (1) | IL244693B (hu) |
| MX (1) | MX370006B (hu) |
| PH (1) | PH12016500577A1 (hu) |
| PL (1) | PL3057963T3 (hu) |
| TW (1) | TW201609716A (hu) |
| UY (1) | UY35785A (hu) |
| WO (1) | WO2015055698A1 (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106854189A (zh) * | 2015-12-08 | 2017-06-16 | 湖南华腾制药有限公司 | 一种哌嗪化合物的合成方法 |
| CN107778257A (zh) * | 2016-08-29 | 2018-03-09 | 湖南华腾制药有限公司 | 一种哌嗪衍生物的合成方法 |
| CN106977463A (zh) * | 2017-05-31 | 2017-07-25 | 湖南华腾制药有限公司 | 一种联苯取代哌嗪衍生物的合成方法 |
| CN107417679A (zh) * | 2017-08-04 | 2017-12-01 | 河南农业大学 | 1,3‑唑类取代吡嗪类化合物的制备方法 |
| JP2023509792A (ja) | 2020-01-09 | 2023-03-09 | ディスク・メディシン・インコーポレイテッド | グリシン輸送阻害剤を用いて骨髄性プロトポルフィリン症、ｘ連鎖プロトポルフィリン症または先天性赤血球生成性ポルフィリン症を処置する方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0224084D0 (en) * | 2002-10-16 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
| GB0505085D0 (en) * | 2005-03-11 | 2005-04-20 | Glaxo Group Ltd | Compounds |
| WO2006113704A2 (en) | 2005-04-18 | 2006-10-26 | Neurogen Corporation | Subtituted heteroaryl cb1 antagonists |
| CN102574857B (zh) | 2009-07-08 | 2015-06-10 | 利奥制药有限公司 | 作为jak受体和蛋白酪氨酸激酶抑制剂的杂环化合物 |
-
2014
- 2014-10-14 US US14/513,918 patent/US9233953B2/en active Active
- 2014-10-15 CA CA2926754A patent/CA2926754C/en active Active
- 2014-10-15 EP EP14784235.5A patent/EP3057963B1/en active Active
- 2014-10-15 WO PCT/EP2014/072085 patent/WO2015055698A1/en active Application Filing
- 2014-10-15 TW TW103135739A patent/TW201609716A/zh unknown
- 2014-10-15 PL PL14784235T patent/PL3057963T3/pl unknown
- 2014-10-15 DK DK14784235.5T patent/DK3057963T3/da active
- 2014-10-15 EA EA201600323A patent/EA029313B1/ru not_active IP Right Cessation
- 2014-10-15 KR KR1020167012860A patent/KR102281284B1/ko active IP Right Grant
- 2014-10-15 AU AU2014336258A patent/AU2014336258B2/en active Active
- 2014-10-15 BR BR112016008062-9A patent/BR112016008062B1/pt active IP Right Grant
- 2014-10-15 JP JP2016523968A patent/JP6483105B2/ja active Active
- 2014-10-15 ES ES14784235T patent/ES2745555T3/es active Active
- 2014-10-15 AR ARP140103834A patent/AR098037A1/es unknown
- 2014-10-15 CN CN201480056368.8A patent/CN105636961B/zh active Active
- 2014-10-15 MX MX2016004847A patent/MX370006B/es active IP Right Grant
- 2014-10-15 HU HUE14784235A patent/HUE047044T2/hu unknown
- 2014-10-16 UY UY0001035785A patent/UY35785A/es unknown
-
2016
- 2016-03-21 IL IL244693A patent/IL244693B/en active IP Right Grant
- 2016-03-30 PH PH12016500577A patent/PH12016500577A1/en unknown
- 2016-04-14 CL CL2016000884A patent/CL2016000884A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20160062187A (ko) | 2016-06-01 |
| BR112016008062B1 (pt) | 2022-11-16 |
| PH12016500577B1 (en) | 2016-06-20 |
| US20150105397A1 (en) | 2015-04-16 |
| WO2015055698A1 (en) | 2015-04-23 |
| JP2016533368A (ja) | 2016-10-27 |
| EA029313B1 (ru) | 2018-03-30 |
| BR112016008062A2 (hu) | 2017-08-01 |
| CA2926754C (en) | 2021-09-14 |
| NZ718251A (en) | 2021-02-26 |
| US9233953B2 (en) | 2016-01-12 |
| IL244693A0 (en) | 2016-04-21 |
| EP3057963B1 (en) | 2019-06-19 |
| TW201609716A (zh) | 2016-03-16 |
| MX2016004847A (es) | 2016-07-19 |
| KR102281284B1 (ko) | 2021-07-23 |
| PL3057963T3 (pl) | 2019-12-31 |
| EA201600323A1 (ru) | 2016-10-31 |
| MX370006B (es) | 2019-11-28 |
| AU2014336258B2 (en) | 2018-07-12 |
| PH12016500577A1 (en) | 2016-06-20 |
| UY35785A (es) | 2015-04-30 |
| CA2926754A1 (en) | 2015-04-23 |
| CN105636961B (zh) | 2019-11-05 |
| CL2016000884A1 (es) | 2016-12-30 |
| AR098037A1 (es) | 2016-04-27 |
| ES2745555T3 (es) | 2020-03-02 |
| IL244693B (en) | 2019-08-29 |
| DK3057963T3 (da) | 2019-09-16 |
| JP6483105B2 (ja) | 2019-03-13 |
| CN105636961A (zh) | 2016-06-01 |
| EP3057963A1 (en) | 2016-08-24 |
| AU2014336258A1 (en) | 2016-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264541B (en) | The history of sulfamoylpyrrolamide and their use as drugs to treat jaundice b | |
| HRP20181863T1 (hr) | Derivati sulfamoiltiofenamida i njihova uporaba kao lijekova za liječenje hepatitisa b | |
| HK1217330A1 (zh) | -苯基-氨甲酰衍生物及其作爲藥物用於治療乙型肝炎的用途 | |
| IL243042A0 (en) | Consequences of aminotriazine and a pharmaceutical preparation containing it | |
| EP3004057A4 (en) | HETEROCYCLIC DERIVATIVES AND THEIR USE | |
| IL244214B (en) | Thienopiperidine derivative and its use | |
| PT3064491T (pt) | Derivado de sulfonamida e sua utilização medicinal | |
| EP2976091C0 (de) | Antioxidativ wirksame zusammensetzung und deren verwendung | |
| IL244693A0 (en) | History of piperazine and their use as drugs | |
| EP3055286A4 (en) | 4-methylsulfonyl-2-butenenitrile and its pharmaceutical use | |
| EP3048886A4 (en) | 3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use | |
| AP2015008814A0 (en) | Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b |